IL106255A0 - Method for isolating human blood cells - Google Patents

Method for isolating human blood cells

Info

Publication number
IL106255A0
IL106255A0 IL106255A IL10625593A IL106255A0 IL 106255 A0 IL106255 A0 IL 106255A0 IL 106255 A IL106255 A IL 106255A IL 10625593 A IL10625593 A IL 10625593A IL 106255 A0 IL106255 A0 IL 106255A0
Authority
IL
Israel
Prior art keywords
blood cells
human blood
isolating human
isolating
cells
Prior art date
Application number
IL106255A
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of IL106255A0 publication Critical patent/IL106255A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL106255A 1993-04-23 1993-07-06 Method for isolating human blood cells IL106255A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5243393A 1993-04-23 1993-04-23

Publications (1)

Publication Number Publication Date
IL106255A0 true IL106255A0 (en) 1993-11-15

Family

ID=21977580

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106255A IL106255A0 (en) 1993-04-23 1993-07-06 Method for isolating human blood cells

Country Status (6)

Country Link
EP (1) EP0695346A1 (en)
JP (1) JPH08509377A (en)
AU (1) AU6559094A (en)
CA (1) CA2160871A1 (en)
IL (1) IL106255A0 (en)
WO (1) WO1994025571A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508528A (en) * 1992-03-23 1994-09-29 ネクセル　セラピューティクス　インコーポレーテッド In vitro derived human neutrophil precursor cells
WO1999015628A1 (en) * 1997-09-25 1999-04-01 Glycotech Corporation Methods and compositions for binding hematopoietic stem cells
CA2316755C (en) * 1998-01-23 2006-04-04 Prolifaron, Inc. Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
WO2007010941A1 (en) * 2005-07-20 2007-01-25 Kaneka Corporation Antigen and monoclonal antibody capable of recognizing the antigen
WO2008087257A1 (en) 2007-01-18 2008-07-24 Suomen Punainen Risti, Veripalvelu Novel methods and reagents directed to production of cells
WO2009103538A1 (en) 2008-02-21 2009-08-27 Baxter International Inc. Procedure for the generation of a high producer cell line for the expression of a recombinant anti-cd34 antibody
EP2625263B1 (en) 2010-10-08 2020-03-11 Terumo BCT, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3122866B1 (en) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
JP2019000063A (en) * 2017-06-19 2019-01-10 東ソー株式会社 Method for exfoliating and recovering undifferentiated cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL54911A0 (en) * 1978-06-15 1978-08-31 Yeda Res & Dev Process for the fractionation of cells
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5081030A (en) * 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices

Also Published As

Publication number Publication date
AU6559094A (en) 1994-11-21
WO1994025571A1 (en) 1994-11-10
JPH08509377A (en) 1996-10-08
CA2160871A1 (en) 1994-11-10
EP0695346A1 (en) 1996-02-07

Similar Documents

Publication Publication Date Title
EP0795007A4 (en) Bioengineered human blood cells
AU624464B2 (en) Skin treatment method
AU6329296A (en) Electrolytic treatment device and method for using same
IL106255A0 (en) Method for isolating human blood cells
HU9301404D0 (en) Method for preparing medical preparatives
AU1624397A (en) Cryogenic well stimulation method
AU1712192A (en) Method for obtaining blood
IL130035A0 (en) Method for conversion of blood type
ZA965191B (en) Cell treatment
GB9422790D0 (en) Method for making stratified tissue
HUP9802706A3 (en) Method for the microbial decontamination of blood platelets
GB9316369D0 (en) Diagnostic method
EP0722330A4 (en) Methods for analysis of human stem cells
GB2270752B (en) Diagnostic method
GB9317585D0 (en) Diagnostic method
IL107586A0 (en) Method for treatment of blood
IL107015A0 (en) Method for treatment of blood
AUPM970594A0 (en) Method and means for separating blood
GB9316836D0 (en) Human cell lines
DE4495155T1 (en) Diagnosis method
GB9303959D0 (en) Treatment method
GB9210170D0 (en) Diagnostic method
GB9218197D0 (en) Diagnostic method
GB9222661D0 (en) Diagnostic method
GB9707698D0 (en) Cell treatment method